Jackson Wealth Management’s Novartis NVS Stock Holding History

Jackson Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-18,844	Closed	-$1.23M	–	72
2016 Q1	$1.23M	Sell	18,844 -429	-2%	-$29.2K	0.47%	50
2015 Q4	$1.42M	Buy	19,273 +40	+0.2%	+$3.18K	0.56%	48
2015 Q3	$1.58M	Buy	19,233 +496	+3%	+$44.1K	0.57%	50
2015 Q2	$1.65M	Sell	18,737 -568	-3%	-$52.1K	0.56%	47
2015 Q1	$1.71M	Sell	19,305 -372	-2%	-$33K	0.55%	63
2014 Q4	$1.63M	Buy	+19,677	New	+$1.63M	0.53%	67

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Jackson Wealth Management's NVS Position: Q2 2016 in Review

Jackson Wealth Management sold out of Novartis (NVS) in Q2 2016, closing a stake of 18,844 shares — an estimated $1.23M sold.

Jackson Wealth Management first reported a position in NVS in Q4 2014 and held it in 6 quarters. The position peaked at $1.71M in Q1 2015. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

Jackson Wealth Management reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
Jackson Wealth Management sold 18,844 Novartis shares in Q2 2016, an estimated $1.23M.
Jackson Wealth Management first reported a position in Novartis in Q4 2014 and held it in 6 quarters.
Jackson Wealth Management's Novartis position peaked at $1.71M in Q1 2015.
878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Jackson Wealth Management's 13F filing for Q2 2016, filed 4 Aug 2016.